Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Daveen Chopra Insider Profile
4 Followers
Daveen Chopra, CVP, TMTT at Edwards Lifesciences, holds 27.58K shares in Edwards Lifesciences (Ticker: EW). Most recently, Daveen Chopra Sold $1,750 shares of Edwards Lifesciences on Dec 06, 2024 for an estimated value of 128.22K.
Profitable Transactions
5 out of 7 Profitable Transactions
Average Return
+9.90%
Average return per transaction
Time Frame
Compare to
Insider Roles
CVP, TMTT
Roles that Daveen Chopra holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Aug 02, 2022 - Aug 02, 2023
Return:+21.30%
The most profitable trade made by Daveen Chopra
Daveen Chopra's Trading History
List of latest transactions for each holding click on a transaction to see Daveen Chopra's performance on stock
You May Also Like
Daveen Chopra insider profile FAQ
What is the percentage of profitable transactions made by Daveen Chopra?
The percentage of profitable transactions made by Daveen Chopra is 71%.
What is the average return per transaction made by Daveen Chopra?
The average return per transaction made by Daveen Chopra is 9.90%.
What stocks does Daveen Chopra hold?
Daveen Chopra holds: EW stocks.
What was Daveen Chopra’s latest transaction?
Daveen Chopra latest transaction was an Informative Sell of $128.22K.
What was Daveen Chopra's most profitable transaction?
Daveen Chopra’s most profitable transaction was an Informative Sell of EW stock on August 2, 2022. The return on the trade was 21.30%.
What is Daveen Chopra's role in Edwards Lifesciences?
Daveen Chopra's role in Edwards Lifesciences is CVP, TMTT.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.